|
Oct 1
|
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years
|
|
Sep 26
|
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies
|
|
May 30
|
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
|
|
May 28
|
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
|
|
Jan 10
|
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
|
|
Dec 19
|
Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
|
|
Dec 6
|
Evotec-partner Jingxin Receives Approval for EVT201 in China
|
|
Dec 4
|
Evotec SE's (ETR:EVT) largest shareholders are individual investors with 47% ownership, institutions own 34%
|
|
Dec 1
|
‘From Hype to Clinical‘: Cowen Suggests 2 AI Healthcare Stocks to Consider
|
|
Sep 27
|
Evotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D Economy
|
|
Sep 26
|
Evotec and Novo Nordisk Launch LAB eN(2) to Accelerate Translation in Cardiometabolic Diseases
|